Mine & Arao Wealth Creation & Management’s GSK GSK Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-640	Closed	-$27.4K	–	187
2024 Q1	$27.4K	Hold	640	–	–	0.01%	168
2023 Q4	$23.7K	Hold	640	–	–	0.01%	173
2023 Q3	$23.2K	Hold	640	–	–	0.01%	173
2023 Q2	$22.8K	Hold	640	–	–	0.01%	182
2023 Q1	$22.8K	Hold	640	–	–	0.01%	181
2022 Q4	$22.5K	Hold	640	–	–	0.02%	177
2022 Q3	$19K	Hold	640	–	–	0.01%	183
2022 Q2	$35K	Hold	640	–	–	0.02%	152
2022 Q1	$35K	Hold	640	–	–	0.02%	167
2021 Q4	$35K	Hold	640	–	–	0.02%	172
2021 Q3	$31K	Hold	640	–	–	0.02%	176
2021 Q2	$32K	Hold	640	–	–	0.02%	167
2021 Q1	$29K	Hold	640	–	–	0.02%	165
2020 Q4	$29K	Hold	640	–	–	0.02%	157
2020 Q3	$30K	Hold	640	–	–	0.02%	145
2020 Q2	$33K	Hold	640	–	–	0.03%	132
2020 Q1	$30K	Hold	640	–	–	0.03%	131
2019 Q4	$38K	Buy	+640	New	+$35.6K	0.04%	138

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's GSK Position: Q2 2024 in Review

Mine & Arao Wealth Creation & Management sold out of GSK (GSK) in Q2 2024, closing a stake of 640 shares — an estimated $27.4K sold.

Mine & Arao Wealth Creation & Management first reported a position in GSK in Q4 2019 and held it in 18 quarters. The position peaked at $38K in Q4 2019. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Mine & Arao Wealth Creation & Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
Mine & Arao Wealth Creation & Management sold 640 GSK shares in Q2 2024, an estimated $27.4K.
Mine & Arao Wealth Creation & Management first reported a position in GSK in Q4 2019 and held it in 18 quarters.
Mine & Arao Wealth Creation & Management's GSK position peaked at $38K in Q4 2019.
884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.